Cornell University, Ithaca
Researchers from the United States and Israel report recent findings in leptospirosis
Published in Pharma Law Weekly, June 20th, 2006
Study 1: Recombinant leptospiral immunoglobulin-like protein A protects against Leptospira interrogans serovar Pomona infection.
"We previously reported the cloning and characterization of leptospiral immunoglobulin-like proteins LigA and LigB of Leptospira interrogans. LigA and LigB are conserved at the amino-terminal region but are variable at the carboxyl-terminal region. Here, we evaluate the potential of recombinant LigA (rLigA) as a vaccine candidate against infection by L. interrogans serovar Pomona in a hamster model. rLigA was truncated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-06-20)
More Articles from Pharma Law Weekly
- Aegate
Pilot study confirms use of Aegate's technology to combat pharmaceutical fraud - Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals to acquire Quill Medical - Biotechnology Industry Organization
BIO names Tom DiLenge as general counsel - Chimerix, Inc.
Chimerix acquires lead compound library of antiviral agents from University of Michigan - Elite Pharmaceuticals, Inc.
Elite enters second pilot Phase I trial of its once-daily oxycodone product - Elsevier MDL
Electronic laboratory notebooks for chemistry and biology are reviewed - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
